Games Global targets up to $276 mln raise in US IPO-February 2024-www.financetom.com

Games Global targets up to $276 mln raise in US IPO

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Games Global targets up to $276 mln raise in US IPO

May 2, 2024 2:53 PM

May 2 (Reuters) - Games Global, the UK-based maker of

online casino-styled games, said on Thursday it was aiming to

raise up to $275.5 million in its initial public offering in the

United States.

(Reporting by Arasu Kannagi Basil in Bengaluru)

Previous page： Update: Market Chatter: Amazon Probing Allegedly Expensive Repair Bills for Delivery Vans Next page： BRIEF-PharmaCorp To Acquire Two Pharmacies In Western Canada For $3.4 Mln

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Update: Market Chatter: Amazon Probing Allegedly Expensive Repair Bills for Delivery Vans

Sep 3, 2025

02:24 PM EDT, 09/03/2025 (MT Newswires) -- (Updates with company statement from a separate report in fifth and sixth paragraphs.) Amazon ( AMZN ) is investigating allegedly expensive repair bills for its aging delivery vans that are used by small businesses to deliver packages, Bloomberg reported Wednesday, citing unnamed sources. The small businesses that use the vans to move packages...

BRIEF-PharmaCorp To Acquire Two Pharmacies In Western Canada For $3.4 Mln

Sep 3, 2025

Sept 3 (Reuters) - PharmaCorp Rx Inc: * PHARMACORP TO ACQUIRE TWO PHARMACIES IN WESTERN CANADA * PHARMACORP RX INC - PURCHASE PRICE FOR ACQUISITIONS IS $3.4 MILLION Source text: Further company coverage: ...

Immunovant Reports 'Encouraging' Data on Graves' Disease Treatment; Shares Rise

Sep 3, 2025

02:27 PM EDT, 09/03/2025 (MT Newswires) -- Immunovant ( IMVT ) reported encouraging data from its study of batoclimab to treat uncontrolled Graves' disease, showing normal thyroid functioning in the majority of the patients during a six-month off-treatment follow-up period. Twenty-five patients received the monoclonal antibody for six months, followed by a 24-week off-treatment observation, and 17 of the 21...

Cannae Holdings Insider Sold Shares Worth $2,478,697, According to a Recent SEC Filing

Sep 3, 2025

02:04 PM EDT, 09/03/2025 (MT Newswires) -- Frank R Martire, Director, on August 29, 2025, sold 133,333 shares in Cannae Holdings ( CNNE ) for $2,478,697. Following the Form 4 filing with the SEC, Martire has control over a total of 199,619 common shares of the company, with 199,619 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1704720/000112760225021115/xslF345X05/form4.xml Price: 18.77, Change: +0.22, Percent...